TNSN98221A1 - Nouvelle forme cristalline d'omeprazole - Google Patents
Nouvelle forme cristalline d'omeprazoleInfo
- Publication number
- TNSN98221A1 TNSN98221A1 TNTNSN98221A TNSN98221A TNSN98221A1 TN SN98221 A1 TNSN98221 A1 TN SN98221A1 TN TNSN98221 A TNTNSN98221 A TN TNSN98221A TN SN98221 A TNSN98221 A TN SN98221A TN SN98221 A1 TNSN98221 A1 TN SN98221A1
- Authority
- TN
- Tunisia
- Prior art keywords
- methoxy
- crystalline form
- new crystalline
- omeprazole
- dimethyle
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
LA PRESENTE INVENTION PORTE SUR UNE NOUVELLE FORME CRISTALLINE DE 5-METHOXY-2-[[4-METHOXY-3,5-DIMETHYLE-2- PYRIDINYLE) METHYLE] SULFINYLE] 1H-BENZIMIDAZOLE, CONNU SOUS LE NOM GENERIQUE D'OMEPRAZOLE. DE PLUS, LA PRESENTE INVENTION PORTE EGALEMENT SUR L'UTILISATION DE LA NOUVELLE FORME CRISTALLINE DE 5-METHOXY-2-[[4-METHOXY - 3,5 - DIMETHYLE -2- PYRIDINYLE]METHYLE)SULFINYLE] 1H-BENZIMIDAZOLE POUR LE TRAITEMENT DE MALADIES GASTROINTESTINALES, SUR LES COMPOSITIONS PHARMACEUTIQUES LE CONTENANT AINSI QUE LES PROCEDES POUR LA PREPARATION DE LA NOUVELLE FORME CRISTALLINE DE 5-METHOXY-2-[[4-METHOXY-3 ,5-DIMETHYLE-2-PYRIDINYLE) METHYLE] SULFINYLE) 1H-BENZIMIDAZOLE.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/SE1998/002028 WO1999008500A2 (fr) | 1998-11-10 | 1998-11-10 | Nouvelle forme cristalline d'omeprazole |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN98221A1 true TNSN98221A1 (fr) | 2005-03-15 |
Family
ID=43735642
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNTNSN98221A TNSN98221A1 (fr) | 1998-11-10 | 1998-12-08 | Nouvelle forme cristalline d'omeprazole |
Country Status (5)
Country | Link |
---|---|
KR (1) | KR100572297B1 (fr) |
AR (1) | AR016700A1 (fr) |
MY (1) | MY118724A (fr) |
SA (1) | SA99190998B1 (fr) |
TN (1) | TNSN98221A1 (fr) |
-
1998
- 1998-11-10 KR KR1020017005830A patent/KR100572297B1/ko not_active IP Right Cessation
- 1998-11-24 MY MYPI98005336A patent/MY118724A/en unknown
- 1998-11-25 AR ARP980105984A patent/AR016700A1/es active IP Right Grant
- 1998-12-08 TN TNTNSN98221A patent/TNSN98221A1/fr unknown
-
1999
- 1999-01-26 SA SA99190998A patent/SA99190998B1/ar unknown
Also Published As
Publication number | Publication date |
---|---|
AR016700A1 (es) | 2001-07-25 |
KR100572297B1 (ko) | 2006-04-24 |
KR20010107953A (ko) | 2001-12-07 |
SA99190998B1 (ar) | 2006-03-25 |
MY118724A (en) | 2005-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN00017A1 (fr) | Sel de potassium d'omeprazole - (s) | |
MY127871A (en) | Omeprazole sodium salt | |
CA2290963A1 (fr) | Trihydrate de magnesium s-omeprazole | |
TR200101282T2 (tr) | Omeprozolün yeni kristalli formu | |
AR079473A2 (es) | Compuesto cristalino de benzimidazol composicion farmaceutica que lo comprende y metodo para la manufactura de dicha composicion | |
IL93263A0 (en) | Antimicrobial pharmaceutical compositions containing a benzimidazole derivative | |
CA2274076A1 (fr) | Nouvelle forme de compose | |
BR9508292A (pt) | Processos para a sintese enãncio-seletiva de um composto,(-)-5-metóxi-2[[(4-metóxi-3,5-dimetil-2-piridinil) metil]sulfinil]-1h-benzimidazol,(+)-5-fluoro-2-(((4-ciclopropilmetóxi-2-piridinil) metil) sulfinil)-1h-benzimidazol,(-)-5-fluoro-2-(((4-ciclopropilmetóxi-2-piridinil) metil) sulfinil)-1h-benzimidazol,(-)-5-fluoro-2-(((4-ciclopropilmetóxi-2-piridinil) metil) sulfinil)-1h-benzimidazol,(-)-5-carbometóxi-6-metil-2-[[(3,4-dimetóxi-2-piridinil) metil] sulfinil]-1h-benzimidazol,(+)-5-carbometóxi-6-metil-2-[[(3,4-dimetóxi-2-piridinil) metil] sulfinil]-1h benzimidazol composto e uso dos compostos | |
TNSN00231A1 (fr) | Forme cristalline de 4-carboxyamino-2-substitue-1,2,3,4- tetrahydroquinoleine, et compositions la contenant | |
TNSN99007A1 (fr) | Composition de mesylate de trovafloxacine et procede pour sa preparation | |
TNSN00112A1 (fr) | Suspensions de ziprasidone nouvelles et procede pour leur preparation. | |
TR199901643T1 (xx) | Yeni y�ntem. | |
NO981856D0 (no) | Anvendelse av 1-(2-naft-2-yletyl)-4-(3-trifluormetylfenyl)-1,2,3,6-tetrahydropyridin for fremstilling av legemidler for behandling av amyotrof lateral sclerose | |
TNSN98221A1 (fr) | Nouvelle forme cristalline d'omeprazole | |
TNSN00142A1 (fr) | Complexe d'eletriptan et d'une sulfobutylether- betacyclodextrine, procede pour sa preparation et compositions pharmaceutiques les contenant. | |
TNSN00105A1 (fr) | Derives de 1-trifluoromethyl-4-hydroxy-7-piperidinyl- aminomethylchromane, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN00095A1 (fr) | Benzolactames et thioamides cycliques substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
MA23429A1 (fr) | Novelle forme galenique de derives de 5-nitro imidazole efficace pour le traitement des parasitoses et des infections de l'ensemble du tractus-gastro-intestinal. | |
YU32301A (sh) | Novi kristalni oblik omeprazola | |
TNSN98033A1 (fr) | Derives de quinoxalinedione, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
TNSN96156A1 (fr) | Formes zwitterioniques de trovafloxacine, procede pour leur preparation et compositions les contenant | |
NO974687D0 (no) | Kondenserte <beta>-carboliner |